Lexicon Pharmaceuticals
LXRX
#7365
Rank
โ‚น40.13 B
Marketcap
โ‚น110.44
Share price
1.65%
Change (1 day)
56.36%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): -โ‚น16.40

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น17.06. In 2024 the company made an earnings per share (EPS) of -โ‚น57.46 an increase over its 2023 EPS that were of -โ‚น71.83.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น16.40-71.46%
2024-โ‚น57.46-20%
2023-โ‚น71.8331.15%
2022-โ‚น54.77-0%
2021-โ‚น54.7710.91%
2020-โ‚น49.38-145.08%
2019โ‚น109.54-206.09%
2018-โ‚น103.26-5.74%
2017-โ‚น109.54-10.95%
2016-โ‚น123.012640%
2015-โ‚น4.49-96.34%
2014-โ‚น122.52-2.53%
2013-โ‚น125.70-9.09%
2012-โ‚น138.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eterna Therapeutics
ERNA
-โ‚น6,888 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น3,900-22,963.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น533.33 3,026.32%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น244.22-1,531.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น1,557-9,226.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น44.89 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น401.35-2,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น214.59-1,357.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น67.34 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA